PlainRecalls
FDA Drug Low Class III Terminated

Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.

Reported: July 30, 2014 Initiated: July 11, 2014 #D-1445-2014

Product Description

Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.

Reason for Recall

Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.

Details

Recalling Firm
Sandoz Inc
Units Affected
781,000 extended release tablets
Distribution
Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.. Recalled by Sandoz Inc. Units affected: 781,000 extended release tablets.
Why was this product recalled?
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 30, 2014. Severity: Low. Recall number: D-1445-2014.